How many of us here now remember this?
From Seeking Alpha July, 2017
Delcath Systems Share Price Has Risen Over 1000% In The Past Month On No News And Is Engaged In Death Spiral Financing
Jul. 12, 2017 11:04 AM•DCTH
Summary
In the past month, Delcath has risen 1000% on promotional hype and no fundamental news.
It's engaging in death spiral financing, and the convertible note holders can buy shares at a 15% discount to the recent market price and immediately sell.
Delcath’s outstanding share count went from 39 million on February 10, 2017, to 374.4 million on June 5th, 2017, to 439.8 million on July 5, 2017.
Delcath is conducting clinical trials on its same technology that the FDA failed to approve in 2013.
.
Despite being a struggling company, Delcath's high spending executives award themselves high salaries, fly first class, and its HQ is located in expensive midtown Manhattan.
Market Data 
Markets 
AI
